You are here

  • Home
  • Archive
  • Volume 107, Issue 5
  • P26 Could the formulation and/or method of administration of oral nadolol have a clinically significant impact on the dose delivered to the patient

Article info

Article menu

Download PDFPDF

ABSTRACTS FROM THE NEONATAL AND PAEDIATRIC PHARMACISTS CONFERENCE 2021
The 27th annual conference was held virtually on 11th and 12th November 2021
Oral presentations
P26 Could the formulation and/or method of administration of oral nadolol have a clinically significant impact on the dose delivered to the patient
Free

Authors

Citation

Aindow A, Edrich C, Corris M, et al
P26 Could the formulation and/or method of administration of oral nadolol have a clinically significant impact on the dose delivered to the patient
Archives of Disease in Childhood 2022;107:e25.

Publication history

  • First published April 20, 2022.
Online issue publication 
September 12, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.